Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2020 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FAT BRANDS INC | 15 | Q2 2024 | 0.6% |
XTANT MED HLDGS INC | 13 | Q2 2024 | 6.2% |
SURROZEN INC | 12 | Q2 2024 | 0.0% |
ADMA BIOLOGICS INC | 11 | Q2 2024 | 6.9% |
CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
INSMED INC | 11 | Q2 2024 | 5.2% |
NEXGEL INC | 11 | Q2 2024 | 0.1% |
NOCTURNE ACQUISITION CORP | 11 | Q1 2024 | 0.1% |
CINGULATE INC | 11 | Q2 2024 | 0.1% |
NLS PHARMACEUTICS LTD | 11 | Q2 2024 | 0.0% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CEMTREX INC | May 08, 2024 | 36,984 | 10.0% |
Sunshine Biopharma, Inc | February 21, 2024 | 3,727,984 | 10.0% |
Evoke Pharma Inc | February 20, 2024 | 822,986 | 9.7% |
ALIMERA SCIENCES INC | February 13, 2024 | 2,660,000 | 5.0% |
Cyclacel Pharmaceuticals, Inc. | February 13, 2024 | 37,982 | 5.0% |
GRI BIO, Inc. | February 13, 2024 | 1,269,210 | 5.0% |
Marpai, Inc.Sold out | February 13, 2024 | 0 | 0.0% |
NovaBay Pharmaceuticals, Inc. | February 13, 2024 | 67,457 | 5.0% |
Volcon, Inc. | February 13, 2024 | 1,666,665 | 9.9% |
Xtant Medical Holdings, Inc. | February 13, 2024 | 8,027,593 | 6.2% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-26 |
SC 13G | 2024-08-16 |
13F-HR | 2024-08-15 |
SC 13G | 2024-08-09 |
SC 13G | 2024-08-09 |
13F-HR | 2024-05-15 |
SC 13G | 2024-05-08 |
SC 13G | 2024-02-21 |
SC 13G | 2024-02-20 |
13F-HR | 2024-02-14 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.